November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
Thinking of Phase IV Trials? Europe Might See Things Differently…
December 3rd 2012With the shadow cast by Mediator across Europe now receding to a focus on the French law courts, the European Union (EU) said in late November that its pharmacovigilance arrangements offer “one of the most advanced and comprehensive systems in the world”.